Description of the prominent features (seen in at least 50% of the patients) included in the classification analysis that statistically define the four clinical groups
| Groups | LE/− n=18 | LE/+n=11 | PNH/+ n=16 | PNH/− n=11 |
| Prominent features (%) | ||||
| Memory impairment | 88.9 | 100 | ||
| Temporal lobe epilepsy | 94.4 | 90.9 | ||
| Dysexecutive syndrome | 77.8 | 63.6 | ||
| Behavioural disorders | 63.6 | |||
| Permanent cerebellar ataxia | 72.7 | |||
| Paroxysmal cerebellar ataxia | 54.5 | |||
| Altered general state | 72.7 | 75.0 | ||
| Weight loss | 72.7 | 56.2 | ||
| PNH | 100 | 100 | ||
| Severe signs of PNH on ENMG | 100 | 54.5 | ||
| Generalised motor symptoms | 81.3 | |||
| Functional impairment due to PNH motor symptoms | 75.0 | |||
| Dysautonomia | 93.8 | |||
| Severe dysautonomia | 68.8 | |||
| Neuropathic pain | 75.0 | 54.5 | ||
| Hyperkinetic movement disorders | 50.0 | |||
| Dyspnoea | 50.0 |
ENMG, electroneuromyography; LE, limbic encephalitis; PNH, peripheral nerve hyperexcitability.